Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis

Open access
Galley, Helen F., Lowes, Damon A., Allen, Lee, Cameron, Gary, Aucott, Lorna S., Webster, Nigel R. · 2014 · Journal of Pineal Research

Abstract

Sepsis is a massive inflammatory response mediated by infection, characterized by oxidative stress, release of cytokines, and mitochondrial dysfunction. Melatonin accumulates in mitochondria, and both it and its metabolites have potent antioxidant and anti‐inflammatory activities and may be useful in sepsis. We undertook a phase I dose escalation study in healthy volunteers to assess the tolerability and pharmacokinetics of 20, 30, 50, and 100 mg oral doses of melatonin. In addition, we developed an ex vivo whole blood model under conditions mimicking sepsis to determine the bioactivity of melatonin and the major metabolite 6‐hydroxymelatonin at relevant concentrations. For the phase I trial, oral melatonin was given to five subjects in each dose cohort (n = 20). Blood and urine were collected for measurement of melatonin and 6‐hydroxymelatonin, and symptoms and physiological measures were assessed. Validated sleep scales were completed. No adverse effects after oral melatonin, other than mild transient drowsiness with no effects on sleeping patterns, were seen, and no symptoms were reported. Melatonin was rapidly cleared at all doses with a median [range] elimination half‐life of 51.7 [29.5–63.2] min across all doses. There was considerable variability in maximum melatonin levels within each dose cohort, but 6‐hydoxymelatonin sulfate levels were less variable and remained stable for several hours. For the ex vivo study, blood from 20 volunteers was treated with lipopolysaccharide and peptidoglycan plus a range of concentrations of melatonin/6‐hydroxymelatonin. Both melatonin and 6‐hydroxymelatonin had beneficial effects on sepsis‐induced mitochondrial dysfunction, oxidative stress, and cytokine responses at concentrations similar to those achieved in vivo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jpi.12134

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Measuring melatonin in humans

    Benloucif, S., Burgess, H. J., Klerman, E. B., Lewy, A. J., Middleton, B., Murphy, P. J., Parry, B. L., & Revell, V. L. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27083 · Cited by 532 · cited 1×

    “Melatonin metabolism has been commonly monitored using measurement of urine excretion of 6-hydroxymelatonin sulfate, with maximum levels up to 2 mg/hr reported to occur between 04:00 and 08:00 but negligible amounts at other times [35]; however, there are few reports of 6-hydroxymelatonin in the serum after oral doses…”
    Method
  • Cytochrome P 450 isoforms involved in melatonin metabolism in human liver microsomes

    Facciolá, G., Hidestrand, M., von Bahr, C., & Tybring, G. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000245 · Cited by 126

Show all 2 references

Cited by

See all 162

Metadata

Authors
Galley, H. F., Lowes, D. A., Allen, L., Cameron, G., Aucott, L. S., & Webster, N. R.
Venue
Journal of Pineal Research
Publisher
Wiley
Published
2014-04-05
Volume
56
Issue
4
Pages
427-438
ISSN
  • 0742-3098 (ISSN-L)
  • 1600-079X
OpenAlex
W2097588095
Cited by
162
References
2
FWCI
5.73
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. https://app.cochat.ai/papers/10.1111/jpi.12134
The paper
Galley, H. F., Lowes, D. A., Allen, L., Cameron, G., Aucott, L. S., & Webster, N. R. (2014). Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. Journal of Pineal Research. https://doi.org/10.1111/jpi.12134

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.